Kawasaki shock syndrome complicating a recurrence of Kawasaki disease

Pediatrics

Volumn 134, Issue 6, 2014, Pages e1695-e1699

  Tissandier, Côme ^a   Lang, Matthieu ^b   Lusson, Jean René ^b,c   Boeuf, Benoit ^b   Merlin, Etienne ^a,c   Dauphin, Claire ^b  

^a INSERM   (France)

^b UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^c UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Case report; Drug therapy combination; Glucocorticoids therapeutic use; Mucocutaneous lymph node syndrome; Mucocutaneous lymph node syndrome diagnosis; Mucocutaneous lymph node syndrome therapy; Recurrence; Shock diagnosis

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; CEFPODOXIME; CLINDAMYCIN; FUROSEMIDE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; NIFLUMIC ACID; SPIRONOLACTONE; AUTACOID;

ABDOMINAL PAIN; ARTICLE; BLOOD ANALYSIS; BLOOD CULTURE; CASE REPORT; CERVICAL LYMPHADENOPATHY; CHEILITIS; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CONJUNCTIVAL HYPEREMIA; CORTICOSTEROID THERAPY; ECHOCARDIOGRAPHY; ECHOGRAPHY; ERYTHEMA; GALLBLADDER DISEASE; HUMAN; HYDROCHOLECYSTIS; KAWASAKI SHOCK SYNDROME; LABORATORY TEST; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NECK PAIN; PHARYNGITIS; PRESCHOOL CHILD; RECURRENT DISEASE; SKIN CULTURE; THROMBOCYTOSIS; BLOOD; DIFFERENTIAL DIAGNOSIS; DOSE RESPONSE; DRUG ADMINISTRATION; HEART FAILURE; HYPOTENSION; INTENSIVE CARE UNIT; MULTIMODALITY CANCER THERAPY; PASSIVE IMMUNIZATION; SHOCK;

ASPIRIN; CHILD; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ECHOCARDIOGRAPHY; HEART FAILURE; HUMANS; HYPOTENSION; IMMUNIZATION, PASSIVE; INFLAMMATION MEDIATORS; INTENSIVE CARE UNITS, PEDIATRIC; MALE; METHYLPREDNISOLONE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RECURRENCE; SHOCK;

EID: 84913537492     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-0004     Document Type: Article

References (27)

1. Perrin L, Letierce A, Guitton C, Tran T-A, Lambert V, Koné-Paut I. Comparative study of complete versus incomplete Kawasaki disease in 59 pediatric patients. Joint Bone Spine. 2009;76(5):481-485
2. Kuo H-C, Yang KD, Chang W-C, Ger L-P, Hsieh K-S. Kawasaki disease: an update on diagnosis and treatment. Pediatr Neonatol. 2012;53(1):4-11
3. Saha A, Khalil S, Kapoor K, Gupta A, Dubey NK. Kawasaki shock syndrome presenting as toxic shock syndrome. Int J Rheum Dis. 2013;16(4):480-482
4. Gámez-González LB, Murata C, Muñoz-Ramírez M, Yamazaki-Nakashimada M. Clinical manifestations associated with Kawasaki disease shock syndrome in Mexican children. Eur J Pediatr. 2013;172(3):337-342
5. Nakamura Y, Yanagawa H. A case-control study of recurrent Kawasaki disease using the database of the nationwide surveys in Japan. Eur J Pediatr. 1996;155(4):303-307
6. Hirata S, Nakamura Y, Yanagawa H. Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan. Acta Paediatr. 2001;90(1):40-44
7. Huang G-Y, Ma X-J, Huang M, et al. Epidemiologic pictures of Kawasaki disease in Shanghai from 1998 through 2002. J Epidemiol. 2006;16(1):9-14
8. Huang W-C, Huang L-M, Chang I-S, et al; Kawasaki Disease Research Group. Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006. Pediatrics. 2009;123(3). Available at: www.pediatrics.org/cgi/content/full/123/3/e401
9. Park Y-W, Park I-S, Kim C-H, et al. Epidemiologic study of Kawasaki disease in Korea, 1997-1999: comparison with previous studies during 1991-1996. J Korean Med Sci. 2002;17(4):453-456
10. Bell DM, Morens DM, Holman RC, Hurwitz ES, Hunter MK. Kawasaki syndrome in the United States 1976 to 1980. Am J Dis Child. 1983;137(3):211-214
11. Nakamura Y, Hirose K, Yanagawa H, Kato H, Kawasaki T. Incidence rate of recurrent Kawasaki disease in Japan. Acta Paediatr. 1994;83(10):1061-1064
12. Yang H-M, Du Z-D, Fu P-P. Clinical features of recurrent Kawasaki disease and its risk factors. Eur J Pediatr. 2013;172(12):1641-1647
13. Zou L-X, Gong F-Q. Clinical features of recurrent Kawasaki disease in 20 children [in Chinese]. Chin J Contemp Pediatr. 2008;10(5):617-619
14. Chen CY, Wu JR. Relapse of Kawasaki disease: a case report [in Chinese]. Gaoxiong Yi Xue Ke Xue Za Zhi. 1989;5(3):189-193
15. Chahal N, Somji Z, Manlhiot C, et al. Rate, associated factors and outcomes of recurrence of Kawasaki disease in Ontario, Canada. Pediatr Int. 2012;54(3):383-387
16. Nakamura Y, Yanagawa H, Ojima T, Kawasaki T, Kato H. Cardiac sequelae of Kawasaki disease among recurrent cases. Arch Dis Child. 1998;78(2):163-165
17. Nakamura Y, Oki I, Tanihara S, Ojima T, Yanagawa H. Cardiac sequelae in recurrent cases of Kawasaki disease: a comparison between the initial episode of the disease and a recurrence in the same patients. Pediatrics. 1998;102(6):E66
18. Guillevin L, Lhote F, Gayraud M, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome: a prospective study in 342 patients. Medicine (Baltimore). 1996;75(1):17-28
19. Nagata S, Yamashiro Y, Ohtsuka Y, et al. Heat shock proteins and superantigenic properties of bacteria from the gastrointestinal tract of patients with Kawasaki disease. Immunology. 2009;128(4):511-520
20. Egami K, Muta H, Ishii M, et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr. 2006;149(2):237-240
21. Chen S, Dong Y, Yin Y, Krucoff MW. Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis. Heart. 2013;99(2):76-82
22. Ogata S, Ogihara Y, Honda T, Kon S, Akiyama K, Ishii M. Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial. Pediatrics. 2012;129(1):e17-e23
23. Yoshikawa H, Nomura Y, Masuda K, et al. Four cases of Kawasaki syndrome complicated with myocarditis. Circ J. 2006;70(2):202-205
24. Moran AM, Newburger JW, Sanders SP, et al. Abnormal myocardial mechanics in Kawasaki disease: rapid response to gamma-globulin. Am Heart J. 2000;139(2 pt 1):217-223
25. Newburger JW, Sanders SP, Burns JC, Parness IA, Beiser AS, Colan SD. Left ventricular contractility and function in Kawasaki syndrome: effect of intravenous gamma-globulin. Circulation. 1989;79(6):1237-1246
26. Kanegaye JT, Wilder MS, Molkara D, et al. Recognition of a Kawasaki disease shock syndrome. Pediatrics. 2009;123(5):e783-e789
27. Chen P-S, Chi H, Huang F-Y, Peng C-C, Chen M-R, Chiu N-C. Clinical manifestations of Kawasaki disease shock syndrome: a case-control study (published online ahead of print August 5, 2013). J Microbiol Immunol Infect. doi.org/10.1016/j.jmii.2013.06.005